Phase II trial of neoadjuvant docetaxel with or without bevacizumab in patients with locally advanced breast cancer.

被引：0
|
作者：
Overmoyer, B
Silverman, P
Leeming, R
Shenk, R
Lyons, J
Jesberger, J
Hartman, P
Dumadag, L
Chen, H
机构：
[1] Univ Hosp Cleveland, Cleveland, OH 44106 USA
[2] NCI, CTEP, Bethesda, MD 20892 USA
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2004年 / 88卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S106 / S106
页数：1
相关论文
共 50 条
  • [21] Phase II trial of neoadjuvant docetaxel before radical prostatectomy for locally advanced prostate cancer
    Dreicer, R
    Magi-Galluzzi, C
    Zhou, M
    Rothaermel, J
    Reuther, A
    Ulchaker, J
    Zippe, C
    Fergany, A
    Klein, EA
    [J]. UROLOGY, 2004, 63 (06) : 1138 - 1142
  • [22] Phase II study of docetaxel, capecitabine, and cisplatin as neoadjuvant chemotherapy for locally advanced breast cancer
    Yen-Shen Lu
    Dar-Ren Chen
    Ling-Min Tseng
    Dah-Cherng Yeh
    Shou-Tung Chen
    Chia-Ming Hsieh
    Hwei-Chung Wang
    Hsien-Tang Yeh
    Sung-Hsin Kuo
    Chiun-Sheng Huang
    [J]. Cancer Chemotherapy and Pharmacology, 2011, 67 : 1257 - 1263
  • [23] Phase II study of docetaxel, capecitabine, and cisplatin as neoadjuvant chemotherapy for locally advanced breast cancer
    Lu, Yen-Shen
    Chen, Dar-Ren
    Tseng, Ling-Min
    Yeh, Dah-Cherng
    Chen, Shou-Tung
    Hsieh, Chia-Ming
    Wang, Hwei-Chung
    Yeh, Hsien-Tang
    Kuo, Sung-Hsin
    Huang, Chiun-Sheng
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (06) : 1257 - 1263
  • [24] A phase I/II study of imatinib and docetaxel as neoadjuvant therapy in locally advanced breast cancer
    Haley, B. B.
    Ashfaq, R.
    DeHaas, M.
    Ramaswami, A.
    Sikder, K.
    Tripathy, D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [25] Phase II Trial of Neoadjuvant Chemotherapy with XELOX plus Bevacizumab for Locally Advanced Rectal Cancer
    Uehara, Keisuke
    Ishiguro, Seiji
    Sakamoto, Eiji
    Maeda, Atsuyuki
    Inoue, Masaya
    Tojima, Yuichiro
    Kobayashi, Satoshi
    Omiya, Naoki
    Ishizuka, Naoki
    Nakao, Akimasa
    Goto, Hidemi
    Nagino, Masato
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 41 (08) : 1041 - 1044
  • [26] Phase II evaluation of bi-weekly docetaxel combined with doxorubicin in patients with locally advanced breast cancer.
    Crew, K
    Tiersten, A
    Vahdat, L
    Frank, T
    Hibshoosh, H
    Smith, S
    Brafman, L
    Schwartzreich, E
    Hershman, D
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 95S - 95S
  • [27] Clinical response to neoadjuvant docetaxel predicts improved outcome in patients with large locally advanced breast cancer.
    Tham, YL
    Gutierrez, C
    Weiss, H
    Mohsin, S
    Hilsenbeck, S
    Elledge, R
    Chamness, G
    Osborne, CK
    Allred, DC
    Chang, JC
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 73S - 73S
  • [28] A Phase II Study of Concurrent Docetaxel, Epirubicin and Cyclophosphamide as a Neoadjuvant Chemotherapy Regimen in Patients with Locally Advanced Breast Cancer
    Yao, Xin
    Hosenpud, Janet
    Chitambar, Christopher R.
    Charlson, John
    Cheng, Yee Chung
    [J]. JOURNAL OF CANCER, 2012, 3 : 145 - 151
  • [29] A PHASE II NEOADJUVANT TRIAL OF GENEXOL® (PACLITAXEL) AND EPIRUBICIN IN LOCALLY ADVANCED BREAST CANCER
    Kim, J.
    Lee, J.
    Ahn, B.
    Jeong, H.
    Byun, W.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 1060 - 1060
  • [30] Exemestane as neoadjuvant hormonotherapy for locally advanced breast cancer: Results of a phase II trial
    Tubiana-Hulin, Michele
    Becette, Veronique
    Bieche, Ivan
    Mauriac, Louis
    Romieu, Gilles
    Bibeau, Frederic
    MacGrogan, Gaetan
    Bourgeois, Hugues
    Chollet, Philippe
    Defrance, Remy
    Spyratos, Frederique
    [J]. ANTICANCER RESEARCH, 2007, 27 (4C) : 2689 - 2696
12345